re: coramsine/spike/egr Agree with this sentiment. While the share price languishes, the value of the projects increase as they move further along the timeline. Sooner or later, a re-rating will come. The technology seems to valuable for this not to occur. It might take a month, it might take a year.
That said, 2005 should be a good year for Solbec. The release of (favorable) announcments regarding psoriasis and cancer will kick things off well and there should be some significant advances towards OD status, phase 2 trials and a partnership agreement. This will change Solbec's image from "highly speculative" to "well established". The market cap will increase as a result.
- Forums
- ASX - By Stock
- SBP
- coramsine
SBP
solbec pharmaceuticals limited
coramsine, page-16
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
SPONSORED BY The Market Online